Gene: CBL

867
C-CBL|CBL2|FRA11B|NSLL|RNF55
Cbl proto-oncogene
protein-coding
11q23.3
Ensembl:ENSG00000110395 MIM:165360 Vega:OTTHUMG00000166170 UniprotKB:P22681
NG_016808.1
PubMed
0   ANCO-SNPs
ND|AD
15   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.925e-1 (AD)  4.116e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HP1BP30.907
HELZ0.899
MED13L0.897
DENND4A0.885
PIKFYVE0.885
ZBTB380.885
IFNAR10.882
CNOT10.882
PEAK10.881
EP3000.881

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.59
OR4F29-0.551
NANOGNB-0.247
SOX3-0.232
APOA1-0.213
REN-0.207
IL25-0.2
SPRR2D-0.195
TNFRSF13B-0.19
RBP1-0.19

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CBL mRNA"28903501
C0888604-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [EGF protein results in increased phosphorylation of CBL protein]"12915106
C5830744,4'-hexafluorisopropylidene diphenol"4,4'-hexafluorisopropylidene diphenol results in increased expression of CBL mRNA"27567155
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA"27188386
C1081234-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine"4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine results in decreased phosphorylation of CBL protein"10092522
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of CBL mRNA22230336|2906747
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CBL mRNA21641981
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CBL mRNA19770486
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of CBL mRNA21298039
D0150812-Naphthylamine2-Naphthylamine results in increased expression of CBL mRNA18247414
C006632arsenic trioxidearsenic trioxide results in increased expression of CBL protein19457607
C006632arsenic trioxide[Bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein]19457607
C015001arsenitearsenite results in increased phosphorylation of CBL protein14511371
C015001arsenitetyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CBL protein]14511371
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CBL mRNA18247414|2187194
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CBL mRNA"20018196
D004958EstradiolEstradiol results in increased expression of CBL mRNA23019147
C044887beta-methylcholinebeta-methylcholine affects the expression of CBL mRNA21179406
C006780bisphenol Abisphenol A affects the methylation of CBL promoter27334623
C006780bisphenol Abisphenol A results in decreased expression of CBL mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of CBL mRNA29097150
D000069286Bortezomib[Bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein]19457607
D002220CarbamazepineCarbamazepine affects the expression of CBL mRNA24752500
D002737ChloropreneChloroprene results in increased expression of CBL mRNA23125180
D019327Copper SulfateCopper Sulfate results in increased expression of CBL mRNA19549813
D016572CyclosporineCyclosporine results in increased expression of CBL mRNA25562108
D002945CisplatinCisplatin results in decreased expression of CBL mRNA27594783
D004008DiclofenacDiclofenac affects the expression of CBL mRNA24752500
C000944dicrotophosdicrotophos results in increased expression of CBL mRNA28302478
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of CBL mRNA26924002
C024629dimethyl phthalatedimethyl phthalate affects the expression of CBL mRNA26924002
D004221DisulfiramDisulfiram results in decreased expression of CBL mRNA20530235
D004237DiuronDiuron results in decreased expression of CBL mRNA25152437
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CBL protein23301498
D004967EstrogensEstrogens promotes the reaction [HCK protein binds to CBL protein]10092522
D000431EthanolEthanol inhibits the reaction [INS1 protein results in increased phosphorylation of and affects the localization of CBL protein]16105861
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CBL mRNA17942748
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CBL mRNA29097150
D005485FlutamideCBL protein affects the reaction [Flutamide results in increased activity of CASP9 protein]16301331
D005485FlutamideCBL protein affects the reaction [Flutamide results in increased expression of BCL2L11 protein]16301331
D005485FlutamideCBL protein affects the reaction [Flutamide results in increased expression of DIABLO protein]16301331
D005485Flutamide[CBL protein affects the susceptibility to Flutamide] which affects the expression of BIRC3 mRNA16301331
D005485Flutamide[CBL protein affects the susceptibility to Flutamide] which affects the expression of BIRC3 protein16301331
D005485FlutamideFlutamide affects the expression of CBL mRNA16301331
D005485FlutamideFlutamide inhibits the reaction [CBL protein affects the expression of DIABLO protein]16301331
D005485FlutamideFlutamide results in decreased expression of and results in decreased phosphorylation of CBL protein16301331
D005485FlutamideFlutamide results in decreased expression of CBL mRNA16301331
C001277geldanamycingeldanamycin results in increased expression of CBL mRNA26705709
D007052IbuprofenIbuprofen results in increased expression of CBL mRNA28201806
D000068877Imatinib Mesylate[tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in increased expression of CBL mRNA19208803
C410337K 7174K 7174 results in increased expression of CBL mRNA24086573
D007854LeadCBL protein affects the reaction [Lead results in decreased expression of PDGFRA protein]17298174
D007854LeadLead results in increased phosphorylation of CBL protein17298174
C008261lead acetateCBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]17298174
C008261lead acetatelead acetate results in increased phosphorylation of CBL protein17298174
D008627Mercuric ChlorideMercuric Chloride results in decreased expression of CBL mRNA27188386
D008627Mercuric ChlorideMercuric Chloride promotes the reaction [HCK protein results in increased phosphorylation of CBL protein]10092522
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of CBL mRNA23179753|2627250
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA"27188386
D008767Methylmercury CompoundsCBL protein affects the reaction [Methylmercury Compounds results in increased ubiquitination of and results in increased degradation of PDGFRA protein]17298174
D008767Methylmercury CompoundsMethylmercury Compounds results in increased phosphorylation of CBL protein17298174
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CBL mRNA"20188158
D015741MetriboloneMetribolone results in increased expression of CBL mRNA16301331
C517284monomethyl phthalatemonomethyl phthalate affects the expression of CBL mRNA26924002
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of CBL mRNA"25554681
D009538NicotineNicotine results in increased expression of CBL mRNA18247414
C007350nitrofennitrofen results in decreased expression of CBL mRNA23143077
C007350nitrofennitrofen results in decreased expression of CBL protein23143077
D010269ParaquatCBL protein affects the reaction [Paraquat results in decreased expression of PDGFRA protein]17298174
D010269ParaquatParaquat results in increased phosphorylation of CBL protein17298174
D052638Particulate MatterParticulate Matter results in decreased expression of CBL mRNA22369193
D010634PhenobarbitalPhenobarbital results in decreased expression of CBL mRNA23091169
D010795Phthalic AcidsPhthalic Acids results in increased expression of CBL mRNA21061450
C059514resveratrolresveratrol results in decreased expression of CBL mRNA25667456
C009166retinol acetateretinol acetate results in increased expression of CBL mRNA16772331
D012834SilverSilver results in decreased expression of CBL mRNA27131904
C009277sodium arsenatesodium arsenate results in decreased expression of CBL mRNA21795629
C009277sodium arsenatesodium arsenate results in increased expression of CBL mRNA21795629
D000952Antigens, Polyomavirus Transforming"Antigens, Polyomavirus Transforming results in increased expression of CBL mRNA"26680231
C534735tetraarsenic tetrasulfide[tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in increased expression of CBL mRNA19208803
C534735tetraarsenic tetrasulfidetetraarsenic tetrasulfide results in increased expression of CBL mRNA19208803
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CBL mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA17942748
D013749TetrachlorodibenzodioxinCBL protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [GRB2 protein binds to SOS1 protein]]9918770
D013749TetrachlorodibenzodioxinCBL protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [SHC1 protein binds to [GRB2 protein binds to SOS1 protein]]]9918770
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased phosphorylation of CBL protein9918770
D013849ThimerosalThimerosal results in decreased expression of CBL mRNA27188386
D013853ThioacetamideThioacetamide results in increased expression of CBL mRNA23411599
D013893ThiramThiram results in decreased expression of CBL mRNA20530235
C009495titanium dioxidetitanium dioxide results in increased expression of CBL mRNA23409001
C483909torcetrapibtorcetrapib results in increased expression of CBL mRNA23228038
C015559trimellitic anhydridetrimellitic anhydride results in increased expression of CBL mRNA19042947
C057693troglitazonetroglitazone results in decreased expression of CBL mRNA28973697
C079836tyrphostin 25tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CBL protein]14511371
C079836tyrphostin 25tyrphostin 25 inhibits the reaction [INS1 protein results in increased phosphorylation of CBL protein]14511371
D014520UrethaneUrethane results in increased expression of CBL mRNA28818685
D001335Vehicle EmissionsVehicle Emissions results in decreased expression of CBL mRNA22369193
C111237vorinostatvorinostat results in decreased expression of CBL mRNA27188386

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0001784phosphotyrosine residue binding-IEA-  
GO:0003700DNA-binding transcription factor activity-TAS2030914  
GO:0004842ubiquitin-protein transferase activity-TAS15465819  
GO:0005154epidermal growth factor receptor binding-IEA-  
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI5668240  7517397  7642581  7657591  7721825  8524328  
8621483  8621719  8626543  8662998  8663231  9092538  
9160881  9716598  9890970  10068674  10092522  10679202  
11067845  11157475  11697890  11741956  11891219  11894095  
11894096  12177062  12727845  12815057  14596919  15090612  
15094368  15556646  15581361  15657067  15677445  15708858  
15737992  15962011  16107303  16219545  16407834  16467851  
16636290  16729043  16893902  16914641  16982329  17020880  
17094785  17141222  17372230  17395426  18273061  18654987  
19268472  19380743  20308550  20562913  20711168  20936779  
21163258  21570973  21706016  22266821  23799367  24255178  
25036637  25241761  25814554  27059931  
GO:0017124SH3 domain binding-IBA21873635  
GO:0017124SH3 domain binding-IPI9447983  
GO:0030971receptor tyrosine kinase binding-IBA21873635  
GO:0036312phosphatidylinositol 3-kinase regulatory subunit binding-IEA-  
GO:0045296cadherin binding-HDA25468996  
GO:0046875ephrin receptor binding-IPI18034775  
GO:0061630ubiquitin protein ligase activity-IBA21873635  
GO:0061630ubiquitin protein ligase activity-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000209protein polyubiquitination-IEA-  
GO:0006355regulation of transcription, DNA-templated-IEA-  
GO:0006511ubiquitin-dependent protein catabolic process-IMP25178484  
GO:0006513protein monoubiquitination-IEA-  
GO:0006974cellular response to DNA damage stimulus-IEA-  
GO:0007165signal transduction-IBA21873635  
GO:0007166cell surface receptor signaling pathway-TAS15465819  
GO:0007173epidermal growth factor receptor signaling pathway-TAS15465819  
GO:0007175negative regulation of epidermal growth factor-activated receptor activity-IBA21873635  
GO:0007179transforming growth factor beta receptor signaling pathway-TAS-  
GO:0008543fibroblast growth factor receptor signaling pathway-TAS-  
GO:0008584male gonad development-IEA-  
GO:0010332response to gamma radiation-IEA-  
GO:0014068positive regulation of phosphatidylinositol 3-kinase signaling-IMP17003487  
GO:0014823response to activity-IEA-  
GO:0016567protein ubiquitination-TAS15465819  
GO:0019221cytokine-mediated signaling pathway-TAS-  
GO:0033574response to testosterone-IEA-  
GO:0035635entry of bacterium into host cell-TAS-  
GO:0036120cellular response to platelet-derived growth factor stimulus-IEA-  
GO:0042059negative regulation of epidermal growth factor receptor signaling pathway-IMP25178484  
GO:0042059negative regulation of epidermal growth factor receptor signaling pathway-TAS-  
GO:0042594response to starvation-IEA-  
GO:0043066negative regulation of apoptotic process-IMP18070883  
GO:0043303mast cell degranulation-IEA-  
GO:0045471response to ethanol-IEA-  
GO:0045742positive regulation of epidermal growth factor receptor signaling pathway-TAS-  
GO:0048260positive regulation of receptor-mediated endocytosis-IMP25178484  
GO:0048260positive regulation of receptor-mediated endocytosis-TAS15465819  
GO:0061024membrane organization-TAS-  
GO:0070102interleukin-6-mediated signaling pathway-TAS-  
GO:0070997neuron death-IEA-  
GO:0071364cellular response to epidermal growth factor stimulus-IEA-  
GO:0090650cellular response to oxygen-glucose deprivation-IEA-  
GO:1901215negative regulation of neuron death-IEA-  
GO:1990090cellular response to nerve growth factor stimulus-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005829cytosol-IDA-  
GO:0005829cytosol-TAS-  
GO:0005886plasma membrane-IBA21873635  
GO:0005886plasma membrane-IDA15465819  
GO:0005886plasma membrane-TAS-  
GO:0005925focal adhesion-IEA-  
GO:0016600flotillin complexcolocalizes_withISS-  
GO:0030426growth cone-IEA-  
GO:0042629mast cell granule-IEA-  
GO:0045121membrane raft-IBA21873635  
GO:0048471perinuclear region of cytoplasm-IEA-  
KEGG ID KEGG Term
hsa04012ErbB signaling pathway
hsa04120Ubiquitin mediated proteolysis
hsa04144Endocytosis
hsa04630Jak-STAT signaling pathway
hsa04660T cell receptor signaling pathway
hsa04910Insulin signaling pathway
hsa05100Bacterial invasion of epithelial cells
hsa05200Pathways in cancer
hsa05220Chronic myeloid leukemia
Reactome ID Reactome Term Evidence
R-HSA-1059683Interleukin-6 signalingTAS
R-HSA-1236382Constitutive Signaling by Ligand-Responsive EGFR Cancer VariantsTAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-1280215Cytokine Signaling in Immune systemIEA
R-HSA-1280218Adaptive Immune SystemTAS
R-HSA-1295596Spry regulation of FGF signalingTAS
R-HSA-1433557Signaling by SCF-KITTAS
R-HSA-1433559Regulation of KIT signalingTAS
R-HSA-162582Signal TransductionTAS
R-HSA-1643685DiseaseTAS
R-HSA-1643685DiseaseIEA
R-HSA-1643713Signaling by EGFR in CancerTAS
R-HSA-168256Immune SystemTAS
R-HSA-168256Immune SystemIEA
R-HSA-170834Signaling by TGF-beta Receptor ComplexTAS
R-HSA-177929Signaling by EGFRTAS
R-HSA-182971EGFR downregulationTAS
R-HSA-190236Signaling by FGFRTAS
R-HSA-199991Membrane TraffickingTAS
R-HSA-2173789TGF-beta receptor signaling activates SMADsTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-449147Signaling by InterleukinsIEA
R-HSA-512988Interleukin-3, 5 and GM-CSF signalingIEA
R-HSA-512988Interleukin-3, 5 and GM-CSF signalingTAS
R-HSA-5637810Constitutive Signaling by EGFRvIIITAS
R-HSA-5637812Signaling by EGFRvIII in CancerTAS
R-HSA-5637815Signaling by Ligand-Responsive EGFR Variants in CancerTAS
R-HSA-5653656Vesicle-mediated transportTAS
R-HSA-5654726Negative regulation of FGFR1 signalingTAS
R-HSA-5654727Negative regulation of FGFR2 signalingTAS
R-HSA-5654732Negative regulation of FGFR3 signalingTAS
R-HSA-5654733Negative regulation of FGFR4 signalingTAS
R-HSA-5654736Signaling by FGFR1TAS
R-HSA-5654738Signaling by FGFR2TAS
R-HSA-5654741Signaling by FGFR3TAS
R-HSA-5654743Signaling by FGFR4TAS
R-HSA-5663202Diseases of signal transductionTAS
R-HSA-5663205Infectious diseaseIEA
R-HSA-5663205Infectious diseaseTAS
R-HSA-6783589Interleukin-6 family signalingTAS
R-HSA-6806834Signaling by METTAS
R-HSA-6807004Negative regulation of MET activityTAS
R-HSA-8848021Signaling by PTK6TAS
R-HSA-8849469PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1TAS
R-HSA-8856825Cargo recognition for clathrin-mediated endocytosisTAS
R-HSA-8856828Clathrin-mediated endocytosisTAS
R-HSA-8875360InlB-mediated entry of Listeria monocytogenes into host cellIEA
R-HSA-8875360InlB-mediated entry of Listeria monocytogenes into host cellTAS
R-HSA-8876384Listeria monocytogenes entry into host cellsIEA
R-HSA-8876384Listeria monocytogenes entry into host cellsTAS
R-HSA-9006927Signaling by Non-Receptor Tyrosine KinasesTAS
R-HSA-9006934Signaling by Receptor Tyrosine KinasesTAS
R-HSA-9006936Signaling by TGF-beta family membersTAS
R-HSA-912631Regulation of signaling by CBLIEA
R-HSA-912631Regulation of signaling by CBLTAS
R-HSA-983695Antigen activates B Cell Receptor (BCR) leading to generation of second messengersTAS
R-HSA-983705Signaling by the B Cell Receptor (BCR)TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
23628113Unravelling the basis of variability in cobalamin levels in the general population. (2013 Nov 14)Andrew TBr J Nutr
25598501Regional brain [(11)C]carfentanil binding following tobacco smoking. (2015 Jun 3)Domino EFProg Neuropsychopharmacol Biol Psychiatry
24828667Small-cell lung cancers in patients who never smoked cigarettes. (2014 Jun)Varghese AMJ Thorac Oncol
24249744Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. (2013 Dec 4)Arendt JFJ Natl Cancer Inst
9038761Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis. (1996 Sep)Wickramasinghe SNJ Clin Pathol
29243410Clinical and radiographic peri-implant parameters and proinflammatory cytokine levels among cigarette smokers, smokeless tobacco users, and nontobacco users. (2018 Feb)Akram ZClin Implant Dent Relat Res
29148235Assessment of interleukin-1beta, interleukin-6, and tumor necrosis factor-Alpha levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smokers with peri-implantitis. (2018 Apr)Abduljabbar TClin Implant Dent Relat Res
27587369Comparison of Peri-Implant Soft Tissue Parameters and Crestal Bone Loss Around Immediately Loaded and Delayed Loaded Implants in Smokers and Non-Smokers: 5-Year Follow-Up Results. (2017 Jan)Al Amri MDJ Periodontol
21772844Molecular mechanisms of cigarette smoke-induced proliferation of lung cells and prevention by vitamin C. (2011)Dey NJ Oncol
21645455[Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC]. (2011 Jun)Jiao XZhongguo Fei Ai Za Zhi
28777038Comparison of Peri-implant Clinical and Radiographic Inflammatory Parameters Among Cigarette and Waterpipe (Narghile) Smokers and Never-smokers. (2017 Aug 4)ALHarthi SSJ Periodontol
29124995Peri-implant soft-tissue parameters and crestal bone levels among narghile smokers and nonsmokers. (2017 Aug)Abduljabbar TInhal Toxicol
23029349Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. (2012)Arendt JFPLoS One
29520801Peri-implant soft tissue inflammatory parameters and crestal bone loss among waterpipe (Narghile) smokers and never-smokers with and without type 2 diabetes mellitus. (2018 Mar 8)Al-Sowygh ZHJ Periodontol
29564945Assessment of matrix metalloproteinase-8 and -9 levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smokers with peri-implantitis. (2018 Feb)Al-Sowygh ZHInhal Toxicol